Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Healthcare Cannabis
Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Teal Valley > Trevali to Release First Quarter 2022 Results on May 4, 2022
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(153)
•••
Comment by kramaswamyon Apr 13, 2022 12:14pm
104 Views
Post# 34600701

RE:RE:RE:RE:RE:Trevali to Release First Quarter 2022 Results on May 4, 2022

RE:RE:RE:RE:RE:Trevali to Release First Quarter 2022 Results on May 4, 2022Depends largely on when those concentrates were sold. My guess is that Q1 is going to be closer to $1.6, and not $1.7.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities